Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29023213

Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2017 Dec 10
First author
Horn L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Lung Cancer Res. 2018 Apr;7(Suppl 2):S91-S94. doi: 10.21037/tlcr.2018.01.14.
    note
    Source null
    related pmid
    29782565
    relationship
    Comment in

Authors and identifiers

  1. name
    Horn L
    type
    Author
  2. name
    Spigel DR
    type
    Author
  3. name
    Vokes EE
    type
    Author
  4. name
    Holgado E
    type
    Author
  5. name
    Ready N
    type
    Author
  6. name
    Steins M
    type
    Author
  7. name
    Poddubskaya E
    type
    Author
  8. name
    Borghaei H
    type
    Author
  9. name
    Felip E
    type
    Author
  10. name
    Paz-Ares L
    type
    Author
  11. name
    Pluzanski A
    type
    Author
  12. name
    Reckamp KL
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Horn L
    type
    Author
  2. name
    Spigel DR
    type
    Author
  3. name
    Vokes EE
    type
    Author
  4. name
    Holgado E
    type
    Author
  5. name
    Ready N
    type
    Author
  6. name
    Steins M
    type
    Author
  7. name
    Poddubskaya E
    type
    Author
  8. name
    Borghaei H
    type
    Author
  9. name
    Felip E
    type
    Author
  10. name
    Paz-Ares L
    type
    Author
  11. name
    Pluzanski A
    type
    Author
  12. name
    Reckamp KL
    type
    Author
bibliography ids
  1. nci-bib-5d95fc145a54a2c8c2311a5d
book metadata
content sha256
36f768e2977a32f9fef4aec8affe3ebc04015482418964b304bdde7406a624f7
document type
citation
dois
  1. 10.1200/JCO.2017.74.3062
electronic publication date
display
2017 Oct 12
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29023213
immutable id
pubmed:29023213@36f768e2977a32f9fef4aec8affe3ebc04015482418964b304bdde7406a624f7
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
35
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3924-3933
volume
35
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Lung Cancer Res. 2018 Apr;7(Suppl 2):S91-S94. doi: 10.21037/tlcr.2018.01.14.
    note
    Source null
    related pmid
    29782565
    relationship
    Comment in
outcomes validated
false
pmid
29023213
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
a040353f4f2b12a66020252bec0dffd20b0765a0c5a047676cfc681497bfc953
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2017 Dec 10
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29023213/
title
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).

Preserved source evidence · Not medical advice